Bullboard - Stock Discussion Forum BIOAGE Labs Inc BIOA

Healthcare Biotechnology

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its lead product candidate, azelaprag, is an orally available small molecule agonist of the apelin receptor (APJ) that was observed to promote metabolism and prevent muscle atrophy during bed rest in a Phase... see more

Add To Watchlist

NDAQ:BIOA - Post Discussion

BIOAGE Labs Inc > Bronstein, Gewirtz & Grossman, LLC Announces an Investigatio

View:

Post by whytestocks on Dec 11, 2024 2:45pm

Bronstein, Gewirtz & Grossman, LLC Announces an Investigatio

BREAKING NEWS: $BIOA Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against BioAge Labs, Inc. (BIOA) and Encourages Stockholders to Learn More About the InvestigationNEW YORK, NY / ACCESSWIRE / December 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BioAge Labs, Inc. ("BioAge Labs" or "the Company") (NASDAQ:BIOA). Investors who purchased BioAge Labs securities are encouraged to obtain additional...BIOA - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against BioAge Labs, Inc. (BIOA) and Encourages Stockholders to Learn More About the Investigation